Claude Afif
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Use and Resistance 6
-
- Antibiotic Resistance in Bacteria 9
- Co-authors
- Issam RaadRay HachemMaha BoktourZiad DaoudHend HannaDimitrios P. KontoyiannisEid AzarJihad Irani
- Journals
- Cancer (3 papers)Emerging infectious diseases (2 papers)Antibiotics (2 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)Clinical Infectious Diseases (1 paper)
- Partner nations
- LebanonUnited StatesBahrain
In The Last Decade
Claude Afif
38 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 105
- Molecular Medicine 269
- Applied Microbiology and Biotechnology 107
- Infectious Diseases 466
- Endocrinology 120
- Emergency Medical Services 160
Countries citing papers authored by Claude Afif
This map shows the geographic impact of Claude Afif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude Afif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude Afif more than expected).
Fields of papers citing papers by Claude Afif
This network shows the impact of papers produced by Claude Afif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude Afif. The network helps show where Claude Afif may publish in the future.
Co-authors
The 25 scholars most cited alongside Claude Afif, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 14 | |
| 3 | 2020 | 13 | |
| 4 | 2020 | 2 | |
| 5 | 2019 | 20 | |
| 6 | 2017 | 84 | |
| 7 | 2015 | 3 | |
| 8 | 2015 | 2 | |
| 9 | Immune thrombocytopenic purpura associated with brucellosis. Case report and review of the literature. | 2011 | 6 |
| 10 | 2008 | 58 | |
| 11 | 2008 | 41 | |
| 12 | 2007 | 54 | |
| 13 | 2006 | 165 | |
| 14 | 2004 | 101 | |
| 15 | 2004 | 85 | |
| 16 | 2003 | 9 | |
| 17 | 2003 | 63 | |
| 18 | 2003 | 2 | |
| 19 | 2003 | 5 | |
| 20 | 2001 | 55 |
About Claude Afif
Claude Afif is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Transplantation, Endocrinology and Small Animals, having authored 39 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (9 papers), Antifungal resistance and susceptibility (7 papers), Fungal Infections and Studies (7 papers), Antibiotic Use and Resistance (6 papers), Bacterial Identification and Susceptibility Testing (4 papers), Pharmaceutical and Antibiotic Environmental Impacts (4 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Vibrio bacteria research studies (3 papers). The work is most often cited by research in Molecular Medicine (269 citations), Applied Microbiology and Biotechnology (107 citations), Infectious Diseases (466 citations), Endocrinology (120 citations) and Emergency Medical Services (160 citations). Claude Afif has collaborated with scholars based in Lebanon, United States and Bahrain. Frequent co-authors include Issam Raad, Ray Hachem, Maha Boktour, Ziad Daoud, Hend Hanna, Dimitrios P. Kontoyiannis, Eid Azar, Jihad Irani, Hagop M. Kantarjian and Stella Major. Their work appears in journals such as Cancer, Emerging infectious diseases, Antibiotics, European Journal of Clinical Microbiology & Infectious Diseases and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.